DOI QR코드

DOI QR Code

Clinical features according to chest radiologic patterns of Mycoplasma pneumonia in children

  • Kim, Young Hyun (Department of Pediatrics, College of Medicine, Yeungnam University) ;
  • Kim, Jin Hyeon (Department of Pediatrics, College of Medicine, Yeungnam University) ;
  • Kim, Sae Yoon (Department of Pediatrics, College of Medicine, Yeungnam University) ;
  • Lee, Young Hwan (Department of Pediatrics, College of Medicine, Yeungnam University)
  • Received : 2016.09.19
  • Accepted : 2016.10.24
  • Published : 2016.11.18

Abstract

Background: Clinical differences in Mycoplasma pneumonia (MP) in children and adolescent patients according to abnormal infiltrate patterns on the chest X-ray were compared. Methods: From 2012 to 2015, patients (n=336) diagnosed with MP at Yeungnam University Medical Center have been classified as eiher lobar pneumonia or bronchopneumonia based on the infilterate patterns observed on chest X-ray. Cases were analyzed retrospectively for gender, age, seasonal incidence rate, main symptoms (fever duration, extrapulmonary symptoms), and laboratory results, including white blood cell count, hemoglobin, platelets, C-reactive protein (CRP), and erythrocyte sedimentation rate (ESR), as well as concurrent respiratory virus infection. Results: The following results were observed. First, lobar pneumonia affected 22.0% of all MP patients and was the most common in preschool children, with a high incidence rate in November and December. Second, lobar pneumonia had a longer fever duration than bronchopneumonia (p<0.001), and also showed significantly higher platelets (336.8 vs. $299.1k/{\mu}L$, p=0.026), ESR (46.3 vs. 26.0 mm/hr, p<0.001) and CRP (4.86 vs. 2.18 mg/dL, p=0.001). Third, viral co-infection was more common in bronchopneumonia (p=0.017), affecting 66.7% of infants and toddlers (p=0.034). Finaly, lobar consolidation was most common in both lower lobes. Conclusion: MP in children has increased in younger age groups, and the rate of lobar pneumonia with severe clinical symptoms is higher in older children.

Keywords

References

  1. Saraya T. The history of Mycoplasma pneumoniae pneumonia. Front Microbiol 2016;7:364.
  2. Waites KB, Talkington DF. Mycoplasma pneumoniae and its role as a human pathogen. Clin Microbiol Rev 2004;17:697-728. https://doi.org/10.1128/CMR.17.4.697-728.2004
  3. Eun BW, Kim NH, Choi EH, Lee HJ. Mycoplasma pneumoniae in Korean children: the epidemiology of pneumonia over an 18-year period. J Infect 2008;56:326-31. https://doi.org/10.1016/j.jinf.2008.02.018
  4. Kang KS, Woo HO. Pattern of occurrence of Mycoplasma pneumoniae pneumonia in admitted children: Southern Central Korea, from 1989 to 2002. J Korean Pediatr Soc 2003;46:474-9. Korean.
  5. Korppi M, Heiskanen-Kosma T, Kleemola M. Incidence of community-acquired pneumonia in children caused by Mycoplasma pneumoniae: serological esults of a prospective, population-based study in primary health care. Respirology 2004;9:109-14. https://doi.org/10.1111/j.1440-1843.2003.00522.x
  6. Phares CR, Wangroongsarb P, Chantra S, Paveenkitiporn W, Tondella ML, Benson RF, et al. Epidemiology of severe pneumonia caused by Legionella longbeachae, Mycoplasma pneumoniae, and Chlamydia pneumoniae: 1-year, population-based surveillance for severe pneumonia in Thailand. Clin Infect Dis 2007;45(12):e147-55. https://doi.org/10.1086/523003
  7. Defilippi A, Silvestri M, Tacchella A, Giacchino R, Melioli G, Di Marco E, et al. Epidemiology and clinical features of Mycoplasma pneumoniae infection in children. Respir Med 2008;102:1762-8. https://doi.org/10.1016/j.rmed.2008.06.022
  8. Youn YS, Lee KY, Hwang JY, Rhim JW, Kang JH, Lee JS, et al. Difference of clinical features in childhood Mycoplasma pneumoniae pneumonia. BMC Pediatr 2010;10:48. https://doi.org/10.1186/1471-2431-10-48
  9. Kim EK, Youn YS, Rhim JW, Shin MS, Kang JH, Lee KY. Epidemiological comparison of three Mycoplasma pneumoniae pneumonia epidemics in a single hospital over 10 years. Korean J Pediatr 2015;58:172-7. https://doi.org/10.3345/kjp.2015.58.5.172
  10. Gao J, Yue B, Li H, Chen R, Wu C, Xiao M. Epidemiology and clinical features of segmental/lobar pattern Mycoplasma pneumoniae pneumonia: a ten-year retrospective clinical study. Exp Ther Med 2015;10:2337-44. https://doi.org/10.3892/etm.2015.2818
  11. Ma YJ, Wang SM, Cho YH, Shen CF, Liu CC, Chi H, et al. Clinical and epidemiological characteristics in children with community-acquired mycoplasma pneumonia in Taiwan: a nationwide surveillance. J Microbiol Immunol Infect 2015;48:632-8. https://doi.org/10.1016/j.jmii.2014.08.003
  12. Guo Q, Li HY, Zhou YP, Li M, Chen XK, Peng HL, et al. Associations of radiological features in Mycoplasma pneumoniae pneumonia. Arch Med Sci 2014;10:725-32.
  13. Hsieh SC, Kuo YT, Chern MS, Chen CY, Chan WP, Yu C. Mycoplasma pneumonia: clinical and radiographic features in 39 children. Pediatr Int 2007;49:363-7. https://doi.org/10.1111/j.1442-200X.2007.02363.x
  14. John SD, Ramanathan J, Swischuk LE. Spectrum of clinical and radiographic findings in pediatric mycoplasma pneumonia. Radiographics 2001;21:121-31. https://doi.org/10.1148/radiographics.21.1.g01ja10121
  15. Lee I, Kim TS, Yoon HK. Mycoplasma pneumoniae pneumonia: CT features in 16 patients. Eur Radiol 2006;16:719-25. https://doi.org/10.1007/s00330-005-0026-z
  16. Reittner P, Muller NL, Heyneman L, Johkoh T, Park JS, Lee KS, et al. Mycoplasma pneumoniae pneumonia: radiographic and high-resolution CT features in 28 patients. AJR Am J Roentgenol 2000;174:37-41. https://doi.org/10.2214/ajr.174.1.1740037
  17. Franquet T. Imaging of pneumonia: trends and algorithms. Eur Respir J 2001;18:196-208. https://doi.org/10.1183/09031936.01.00213501
  18. Lin CJ, Chen PY, Huang FL, Lee T, Chi CS, Lin CY. Radiographic, clinical, and prognostic features of complicated and uncomplicated community-acquired lobar pneumonia in children. J Microbiol Immunol Infect 2006;39:489-95.
  19. Meyer Sauteur PM, Unger WW, Nadal D, Berger C, Vink C, van Rossum AM. Infection with and carriage of Mycoplasma pneumoniae in children. Front Microbiol 2016;7:329.
  20. Narita M, Tanaka H. Cytokines involved in the severe manifestations of pulmonary diseases caused by Mycoplasma pneumoniae. Pediatr Pulmonol 2007;42:397. https://doi.org/10.1002/ppul.20445
  21. Hong KB, Choi EH, Lee HJ, Lee SY, Cho EY, Choi JH, et al. Macrolide resistance of Mycoplasma pneumoniae, South Korea, 2000-2011. Emerg Infect Dis 2013;19:1281-4. https://doi.org/10.3201/eid1908.121455
  22. Seo YH, Kim JS, Seo SC, Seo WH, Yoo Y, Song DJ, et al. Predictive value of C-reactive protein in response to macrolides in children with macrolide-resistant Mycoplasma pneumoniae pneumonia. Korean J Pediatr 2014;57:186-92. https://doi.org/10.3345/kjp.2014.57.4.186
  23. Zhou Y, Zhang Y, Sheng Y, Zhang L, Shen Z, Chen Z. More complications occur in macrolide-resistant than in macrolidesensitive Mycoplasma pneumoniae pneumonia. Antimicrob Agents Chemother 2014;58:1034-8. https://doi.org/10.1128/AAC.01806-13